The article by Wasif et al1 published in the February 2010 issue of the Archives has brought another controversial issue to readers as well as to breast oncologists and breast oncologic surgeons. This issue has been dealt with in detail in a recent Consensus Conference III of an interdisciplinary group of physicians who are involved in the treatment of breast diseases.2 This elite group of physicians feels that micrometastasis currently warrants neither axillary lymph node dissection (ALND) nor any adjuvant treatment, based on the fact that micrometastasis does not have an additional risk of axillary failure. These 2 scientific articles raise important questions for both academic and nonacademic breast surgeons:
Badruddoja M. Micrometastasis and Axillary Dissection in Breast Cancer. Arch Surg. 2010;145(10):1022–1023. doi:10.1001/archsurg.2010.214
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.